Training doctors to improve patient decision-making in colorectal cancer screening
Impact of Training in the Patient-centered Approach on Shared Decision-making in the Colorectal Cancer Screening: a Cluster Randomized Trial
This study tests whether training doctors to communicate better with patients can help more people get screened for colorectal cancer.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 50 Years to 74 Years |
| Sex | All |
| Sponsor | CNGE Conseil Academic / other |
| Locations | 1 site (Soisy-sous-Montmorency) |
| Trial ID | NCT06074536 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of face-to-face training for general practitioners on implementing a patient-centered approach to shared decision-making in colorectal cancer screening. It addresses the declining participation rates in screening programs by enhancing communication between physicians and patients. The study will compare outcomes between trained practitioners and those using standard practices without specific training. By focusing on improving the quality of information and communication, the study seeks to increase screening rates among eligible patients.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 50 to 74 who are eligible for organized colorectal cancer screening and have a general practitioner participating in the study.
Not a fit: Patients who have been screened for colorectal cancer within the last two years or those with specific medical histories that exclude them from screening will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase participation rates in colorectal cancer screening, leading to earlier detection and improved patient outcomes.
How similar studies have performed: Other studies have shown that training healthcare providers in patient-centered communication can improve screening rates, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Patient aged 50 to 74:
* Eligible for organized CRC screening,
* Having declared as attending clinician a general practitioner investigator of the study
✓ Consulting their attending clinician for the duration of the study,
* AND able and willing to comply with all trial requirements
Non inclusion Criteria:
\- ✓ Screened for CRC less than 2 years ago
* Not eligible for organized CRC screening:
* History of adenomas or CRC:
\- Family (1st degree)
* Personal history of IBD:
* Crohn's disease
* Ulcerative colitis)
* Hereditary predispositions:
* Familial adenomatous polyposis
* Hereditary non-polyposis colorectal cancer (Lynch syndrome)
* Patient with symptoms requiring colonoscopy
* Having a level of literacy that does not allow the completion of the self-questionnaire.
* Having an inability to give express consent.
* Being under guardianship, curatorship or having cognitive disorders
Where this trial is running
Soisy-sous-Montmorency
- Cabinet de groupe pluriprofessionnel — Soisy-sous-Montmorency, France (Recruiting)
Study contacts
- Study coordinator: Isabelle AUGER-AUBIN, Pr
- Email: isabelle.auger-aubin@u-paris.fr
- Phone: 06 83 28 26 36
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.